Protagonist Therapeutics, Inc. (PTGX) Sentiment Analysis | MarketCI

PT

PTGX

Market Closed

Protagonist Therapeutics, Inc.

NASDAQHealthcare Biotechnology

US

132 employees

CEO: Dinesh V. Patel

Founded: 2016

$136.11

+$0.00(+NaN%)

Market Cap

8.75B

Beta

1.79

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Overall Sentiment

No sentiment data available

News Media

No news sentiment data available

Social Media

No social media data available

Wall Street Analysts

No analyst recommendation data available

Social Sentiment & Market Signals

Real-time social media buzz and conversation analysis

No social sentiment data available

Social media conversation data will appear here once loaded

News Sentiment Risk Analysis

Market sentiment and news coverage impact assessment

Loading news sentiment...

Analyst Recommendations

Wall Street analyst consensus and rating distribution

No Analyst Data Available

Analyst recommendations are not available for this stock

Explore PTGX

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

PTGX in the Healthcare

Mid Cap

Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →